Literature DB >> 17261816

Our moral obligations in caring for patients with orphan cancers.

Conrad V Fernandez.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17261816      PMCID： PMC1780094          DOI： 10.1503/cmaj.061623

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  1 in total

1.  Ethical issues in funding orphan drug research and development.

Authors:  C A Gericke; A Riesberg; R Busse
Journal:  J Med Ethics       Date:  2005-03       Impact factor: 2.903
  1 in total
  2 in total

1.  The End-of-Life Experience of Patients With Rare Cancers and Their Caregivers.

Authors:  Elizabeth Trice Loggers; Holly G Prigerson
Journal:  Rare Tumors       Date:  2014-03-24

2.  Differences in health care experiences between rare cancer and common cancer patients: results from a national cross-sectional survey.

Authors:  Eline de Heus; Vivian Engelen; Irene Dingemans; Carol Richel; Marga Schrieks; Jan Maarten van der Zwan; Marc G Besselink; Mark I van Berge Henegouwen; Carla M L van Herpen; Saskia F A Duijts
Journal:  Orphanet J Rare Dis       Date:  2021-06-01       Impact factor: 4.123
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.